Yahoo Finance9h
French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance
We're delighted to support the company as it embarks on Phase 1 trials in the months ahead.” Amy Salzhauer, managing Partner at Good Growth Capital said: “PATAS is the first, therapeutic breakthrough ...
Digi Times14h
Advantech expands North American operations to meet growing global market demand
Following Donald Trump's re-election, industry observers are monitoring potential policy impacts across sectors. Advantech, a ...